Marbofloxacin: Veterinary Fluoroquinolone Antibiotic
Marbofloxacin is a synthetic third-generation fluoroquinolone antibiotic developed exclusively for veterinary use. It acts by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, preventing DNA replication and transcription. Marbofloxacin exhibits concentration-dependent bactericidal activity against a broad spectrum of gram-positive and gram-negative organisms.
Product Profile
| CAS Number | 115550-35-1 |
|---|---|
| Molecular Formula | C17H19FN4O4 |
| Appearance | White to pale yellow crystalline powder |
| Therapeutic Category | Veterinary Fluoroquinolone Antibiotic |
| Storage | Store at controlled room temperature, protect from light |
Applications
Marbofloxacin is approved for use in dogs, cats, and cattle. In companion animals, it is indicated for skin and soft tissue infections, urinary tract infections, and wound infections caused by susceptible bacteria. In cattle, it is used for respiratory infections (bovine respiratory disease) and acute mastitis. The compound is formulated as oral tablets for companion animals and as injectable solutions for livestock. Its favorable pharmacokinetic profile allows once-daily dosing in most species.
Why Source from TCS
TCS supplies marbofloxacin to veterinary pharmaceutical companies across Europe and globally. Flexible order quantities from development samples to commercial volumes. Contact us with your target market and project requirements for a tailored quotation.
FAQ
What information should be included in an inquiry for Marbofloxacin 115550-35-1?
A useful inquiry normally includes the product name, target application, estimated quantity, destination market, and any specific documentation or packaging requests.
How is Marbofloxacin 115550-35-1 usually evaluated for sourcing?
This product is positioned for pharmaceutical sourcing discussions covering development, pilot, or commercial demand, subject to the buyer confirming application scope, market, and document requirements.
What documentation and commercial points are commonly reviewed before buying Marbofloxacin 115550-35-1?
For pharmaceutical API procurement, buyers commonly align on specification review, target market, batch or annual demand, packaging expectations, and the documentation package needed for the project.
Request a Quote
If your team already has a target application, estimated quantity, destination market, or documentation requirements, send those details so the commercial response can be prepared more efficiently.